Takeda Pharmaceutical
TAK
#370
Rank
HK$528.48 B
Marketcap
HK$165.42
Share price
0.33%
Change (1 day)
55.15%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): HK$3.97 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.55 Billion. In 2025 the company made an earning of HK$26.08 Billion, an increase over its 2024 earnings that were of HK$17.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$3.97 B-84.78%
2025 HK$26.08 B49.03%
2024 HK$17.50 B-2.41%
2023 HK$17.93 B-28.14%
2022 HK$24.95 B-40.9%
2021 HK$42.22 B78.24%
2020 HK$23.69 B246.1%
2019 HK$6.84 B-48.79%
2018 HK$13.36 B-23.64%
2017 HK$17.50 B21.7%
2016 HK$14.38 B-253.01%
2015 -HK$9.4 Billion-159.65%
2014 HK$15.75 B13%
2013 HK$13.94 B2.46%
2012 HK$13.61 B-57.05%
2011 HK$31.68 B-10.49%
2010 HK$35.39 B-3.99%
2009 HK$36.86 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$146.83 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$99.16 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$54.17 B 1,236.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.68 B 1,891.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$56.16 B 1,285.97%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$60.31 B 1,388.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$56.11 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.21 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$3.35 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India